Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioDuro-Sundia is a leading global contract research, development, and manufacturing organization (CRDMO) that provides integrated solutions for drug discovery and development. Formed by the merger of BioDuro and Sundia MediTech, the company offers a comprehensive suite of services across both small molecule and biologics modalities. Their biologics division, often referred to as BioDuro Biologics, specializes in cell line development, process development, and GMP manufacturing for antibodies and recombinant proteins. With major operations in China and the United States, the company supports biopharmaceutical clients from early-stage lead optimization through to clinical trial material production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioDuro Biologics.